Management of tracheal and bronchial stenoses with the Gianturco stent.
Thirty-six cancer patients with symptomatic tracheobronchial stenoses received Gianturco tracheobronchial stents over a 9-year period. Symptoms improved in 28 patients (78%). The overall median survival was 1 month 3 weeks (range, 4 days to 35 months). The median survival for patients who showed improvement after receiving stents was 3 months compared with 1 week for those who did not respond. Complications were minimal. The Gianturco stent may palliate symptoms of tracheobronchial compression in selected cancer patients.
Carrasco
C H
CH
Department of Diagnostic Radiology, University of Texas M.D. Anderson Cancer Center, Houston.
Nesbitt
J C
JC
Charnsangavej
C
C
Ryan
B
B
Walsh
G L
GL
Yasumori
K
K
Lawrence
D D
DD
Wallace
S
S
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001982:Bronchial Diseases / Q000209:etiology / Q000401:mortality / Q000628:therapy*; D003251:Constriction, Pathologic; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications; D010166:Palliative Care; D015607:Stents; D016019:Survival Analysis; D014135:Tracheal Stenosis / Q000209:etiology / Q000401:mortality / Q000628:therapy*; D016896:Treatment Outcome